Skin disease
- Humans1
- In silico1
Trial sponsors
Company1 trialPhase 3838 people
Company1 trialPhase 128 people
1 trialEarly phase 130 people
Funding
1 grant since 2023National Institute of Arthritis and Musculoskeletal and Skin DiseasesUS$503.1k
Latest
20 in 12 monthsarXiv
From the Drosophila Visual Connectome to General-Purpose Computer Vision
Preprint: computational studyAI & data
JACC Advances
Life-Course Noncardiac Comorbidity Burden and Mortality in Lower-Complexity Congenital Heart Disease
Cohort study of 492,232 peoplePopulations
Acta Dermato-venereologica
Physical Activity and Risk of Autoimmune Bullous Skin Diseases: A Prospective Cohort Study
Cohort study of 476,057 peopleSkin
PLOS Biology
Regeneration programs buffer genetic defects in animal development
Experiments in zebrafishMechanisms
The British Journal of Dermatology
Incidence, prevalence, and life expectancy of patients with generalised pustular psoriasis in England: a population-based cohort study exploring ethnic and sex variations
Cohort study in peoplePopulations
Frontiers in Medicine
Glucagon-like peptide-1 receptor agonists and tirzepatide are associated with reduced mortality, cardiovascular, and psychiatric risks in patients with hidradenitis suppurativa and type 2 diabetes and/or obesity: a retrospective cohort study
Cohort study of 8,564 peopleGLP-1 receptor agonists
Materials Today Bio
Development of nanoparticles loaded with D-mannose for topical treatment to alleviate skin aging via rescuing SIRT1 from degradation
Experiments in miceSkin